Amryt

4 results

Reimbursement decisions in France and the UK led to revenue growth for one drug of 28.1 per cent in the first quarter of 2019 compared with a year earlier. Photograph: iStock

Irish pharmaceutical company Amryt said its revenues rose 13.3 per cent in 2018 to €14.5 million and the strong momentum continued into the first quar(...)

Photograph: iStock

Biopharmaceutical firm Amryt said it had a strong year in 2017 as revenue rose to almost €13 million. The company, which focuses on rare and orphan (...)

Photograph: iStock

Irish biopharmaceutical firm Amryt has signed a new distribution agreement, its fourth in recent months. The company, whcih focuses on rare diseases(...)

Amryt has reached a deal to sell a treatment for a cholesterol disorder that can lead to heart attacks in childhood.

Shares in Amryt, the Dublin-listed pharmaceutical company focused on developing treatments for rare or “orphan” diseases, surged as much as 18 per cen(...)